SCHEMBL4259465

SCHEMBL4259465

CCCCOC(=O)N=C(N)n1cccn1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 9/20 0.56
L3MBTL1 Q9Y468 2/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566478 0.78 NOS1 (0.46) NOS1L3MBTL1TSHRTDP1
SCHEMBL14936428 0.78 NOS1 (0.49) NOS1
SCHEMBL9012049 0.78 NOS1 (0.61) NOS1
SCHEMBL9011965 0.76 NOS1 (0.44) NOS1
SCHEMBL4249587 0.75 NOS1 (0.36) NOS1L3MBTL1
SCHEMBL1728940 0.75 NOS1 (0.45) NOS1
SCHEMBL12446838 0.74 NOS1 (0.45) NOS1
SCHEMBL16945673 0.74 NOS1 (0.45) NOS1
SCHEMBL15366422 0.71 NOS1 (0.51) NOS1
SCHEMBL1126448 0.70 ALDH1A1 (0.50) L3MBTL1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368023-A1 DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS Institut National de la Sante et de la Recherche Medicale (INSERM) (FR) 2018-09-05 EP disclosed
WO-2017072319-A1 DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2017-05-04 WO disclosed
WO-2009049028-A1 PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USE AS JANUS KINASE MODULATORS TARGEGEN INC. (US) 2009-04-16 WO disclosed
EP-1828109-A2 GUANIDINE DERIVATIVES AS INHIBITORS OF DDAH UCL Business PLC (GB) 2007-09-05 EP disclosed
WO-2006051314-A2 GUANIDINE DERIVATIVES AS INHIBITORS OF DDAH UCL BUSINESS PLC (GB) 2006-05-18 WO disclosed
US-20020055094-A1 Method of detection of influenza virus and compounds for use therein REECE PHILLIP A (AU) 2002-05-09 US disclosed
EP-0885391-A4 METHOD OF DETECTION OF INFLUENZA VIRUS AND COMPOUNDS FOR USE THEREIN BIOTA SCIENT MANAGEMENT (AU) 2001-07-25 EP disclosed
EP-1009770-A1 PEPTIDES CONTAINING AN ARGININE MIMETIC FOR THE TREATMENT OF BONE METABOLIC DISORDERS, THEIR PRODUCTION, AND DRUGS CONTAINING THESE COMPOUNDS Roche Diagnostics GmbH (DE) 2000-06-21 EP disclosed
WO-1999012970-A1 PEPTIDES CONTAINING AN ARGININE MIMETIC FOR THE TREATMENT OF BONE METABOLIC DISORDERS, THEIR PRODUCTION, AND DRUGS CONTAINING THESE COMPOUNDS ROCHE DIAGNOSTICS GMBH (DE) 1999-03-18 WO disclosed
EP-0885391-A1 METHOD OF DETECTION OF INFLUENZA VIRUS AND COMPOUNDS FOR USE THEREIN BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1998-12-23 EP disclosed
EP-0865445-A1 3-AMINOETHYL-N-AMIDINO-2,5-DIHYDROPYRROLE DERIVATIVES HAVING ARGININE MIMETIC PROPERTIES Roche Diagnostics GmbH (DE) 1998-09-23 EP disclosed
WO-1997032214-A1 METHOD OF DETECTION OF INFLUENZA VIRUS AND COMPOUNDS FOR USE THEREIN BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1997-09-04 WO disclosed
WO-1997021725-A1 3-AMINOETHYL-N-AMIDINO-2,5-DIHYDROPYRROLE DERIVATIVES HAVING ARGININE MIMETIC PROPERTIES BOEHRINGER MANNHEIM GMBH (DE) 1997-06-19 WO disclosed